Danaher turned in second-quarter results including 3% core revenue growth to $6.3 billion (above FactSet consensus of $6.1 billion) and 8% adjusted EPS growth to $1.94 (above consensus of $1.84.) Management also increased its EPS outlook a bit but trimmed its core revenue growth assumption.
The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.
Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.43 | 16.49 | 16.08 |
Price/Book Value | 2.39 | 1.96 | 7.63 |
Price/Sales | 5.16 | 2.78 | 4.31 |
Price/Cash Flow | 17.69 | 12.54 | 14.13 |
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Quick Ratio | 1.28 | 0.91 | 1.10 |
Current Ratio | 1.87 | 1.51 | 1.38 |
Interest Coverage | 17.75 | 8.57 | 13.46 |
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Return on Assets (Normalized) | — | 5.46% | 15.77% |
Return on Equity (Normalized) | — | 9.48% | 49.73% |
Return on Invested Capital (Normalized) | — | 7.51% | 23.68% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|p$KG%&@R | LOCK|m? | $195B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|?$Gc&%! | LOCK|L> | $44B | |||
| Agilent Technologies Inc
A
| LOCK|cK<DG^NS | LOCK|#fm | $38B | |||
| Waters Corp
WAT
| LOCK|$$<Fnb | LOCK|gb& | $36B | |||
| IQVIA Holdings Inc
IQV
| LOCK|@sf%!& | LOCK|F<@l | $34B | |||
| Illumina Inc
ILMN
| LOCK|WH$Q@$t | LOCK|#d!& | $29B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|ZT@TtKW! | LOCK|Y&x$@ | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|&>^sQ#G% | LOCK|qZ@G | $23B | |||
| Quest Diagnostics Inc
DGX
| LOCK|bGx<K<M | LOCK|XLF!X | $23B |
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/27df33e4-c5eb-4dc8-805e-babc7c688b65.jpg)
United States